These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32458234)

  • 1. Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF.
    Wang L; Du WQ; Xie M; Liu MR; Huo FC; Yang J; Pei DS
    Gastric Cancer; 2020 Nov; 23(6):1003-1017. PubMed ID: 32458234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF.
    Ko A; Shin JY; Seo J; Lee KD; Lee EW; Lee MS; Lee HW; Choi IJ; Jeong JS; Chun KH; Song J
    J Natl Cancer Inst; 2012 Nov; 104(21):1660-72. PubMed ID: 23104211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
    Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
    Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
    J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the Chemopreventive Role of Stigmasterol Against Jab1 in Gall Bladder Carcinoma.
    Pandey P; Bajpai P; Siddiqui MH; Sayyed U; Tiwari R; Shekh R; Mishra K; Kapoor VK
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):826-837. PubMed ID: 30727937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.
    Li J; Li Y; Wang B; Ma Y; Chen P
    Biochem Biophys Res Commun; 2018 Jun; 500(2):132-138. PubMed ID: 29596838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.
    Samsa WE; Mamidi MK; Bashur LA; Elliott R; Miron A; Chen Y; Lee B; Greenfield EM; Chan R; Danielpour D; Zhou G
    Oncogene; 2020 Jun; 39(23):4581-4591. PubMed ID: 32390003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.
    Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W
    Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSN6 promotes the cell migration of breast cancer cells by positively regulating Snail1 stability.
    Mou J; Wei L; Liang J; Du W; Pei D
    Int J Med Sci; 2020; 17(17):2809-2818. PubMed ID: 33162808
    [No Abstract]   [Full Text] [Related]  

  • 11. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.
    Xiao H; Claret FX; Shen Q
    Neoplasma; 2019 May; 66(3):481-486. PubMed ID: 30868895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting
    Pandey P; Khan F; Alzahrani FA; Qari HA; Oves M
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome.
    Pandey P; Siddiqui MH; Behari A; Kapoor VK; Mishra K; Sayyed U; Tiwari RK; Shekh R; Bajpai P
    Anticancer Agents Med Chem; 2019; 19(16):2019-2033. PubMed ID: 31345154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging roles of Jab1/CSN5 in cancer.
    Wang L; Zheng JN; Pei DS
    Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
    Wei Y; Liu G; Wu B; Yuan Y; Pan Y
    Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.
    Deng T; Shen P; Li A; Zhang Z; Yang H; Deng X; Peng X; Hu Z; Tang Z; Liu J; Hou R; Liu Z; Fang W
    Theranostics; 2021; 11(16):8112-8128. PubMed ID: 34335983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
    Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
    Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
    Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.